Cargando…
Combined 3D-QSAR and Docking Modelling Study on Indolocarbazole Series Compounds as Tie-2 Inhibitors
Tie-2, a kind of endothelial cell tyrosine kinase receptor, is required for embryonic blood vessel development and tumor angiogenesis. Several compounds that showed potent activity toward this attractive anticancer drug target in the assay have been reported. In order to investigate the structure-ac...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Molecular Diversity Preservation International (MDPI)
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3179154/ https://www.ncbi.nlm.nih.gov/pubmed/21954347 http://dx.doi.org/10.3390/ijms12085080 |
_version_ | 1782212489684975616 |
---|---|
author | Tian, Yuanxin Xu, Jian Li, Zhonghuang Zhu, Zhengguang Zhang, Jiajie Wu, Shuguang |
author_facet | Tian, Yuanxin Xu, Jian Li, Zhonghuang Zhu, Zhengguang Zhang, Jiajie Wu, Shuguang |
author_sort | Tian, Yuanxin |
collection | PubMed |
description | Tie-2, a kind of endothelial cell tyrosine kinase receptor, is required for embryonic blood vessel development and tumor angiogenesis. Several compounds that showed potent activity toward this attractive anticancer drug target in the assay have been reported. In order to investigate the structure-activity correlation of indolocarbazole series compounds and modify them to improve their selectivity and activity, 3D-QSAR models were built using CoMFA and CoMSIA methods and molecular docking was used to check the results. Based on the common sketch align, two good QSAR models with high predictabilities (CoMFA model: q(2) = 0.823, r(2) = 0.979; CoMSIA model: q(2) = 0.804, r(2) = 0.967) were obtained and the contour maps obtained from both models were applied to identify the influence on the biological activity. Molecular docking was then used to confirm the results. Combined with the molecular docking results, the detail binding mode between the ligands and Tie-2 was elucidated, which enabled us to interpret the structure-activity relationship. These satisf actory results not only offered help to comprehend the action mechanism of indolocarbazole series compounds, but also provide new information for the design of new potent inhibitors. |
format | Online Article Text |
id | pubmed-3179154 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | Molecular Diversity Preservation International (MDPI) |
record_format | MEDLINE/PubMed |
spelling | pubmed-31791542011-09-27 Combined 3D-QSAR and Docking Modelling Study on Indolocarbazole Series Compounds as Tie-2 Inhibitors Tian, Yuanxin Xu, Jian Li, Zhonghuang Zhu, Zhengguang Zhang, Jiajie Wu, Shuguang Int J Mol Sci Article Tie-2, a kind of endothelial cell tyrosine kinase receptor, is required for embryonic blood vessel development and tumor angiogenesis. Several compounds that showed potent activity toward this attractive anticancer drug target in the assay have been reported. In order to investigate the structure-activity correlation of indolocarbazole series compounds and modify them to improve their selectivity and activity, 3D-QSAR models were built using CoMFA and CoMSIA methods and molecular docking was used to check the results. Based on the common sketch align, two good QSAR models with high predictabilities (CoMFA model: q(2) = 0.823, r(2) = 0.979; CoMSIA model: q(2) = 0.804, r(2) = 0.967) were obtained and the contour maps obtained from both models were applied to identify the influence on the biological activity. Molecular docking was then used to confirm the results. Combined with the molecular docking results, the detail binding mode between the ligands and Tie-2 was elucidated, which enabled us to interpret the structure-activity relationship. These satisf actory results not only offered help to comprehend the action mechanism of indolocarbazole series compounds, but also provide new information for the design of new potent inhibitors. Molecular Diversity Preservation International (MDPI) 2011-08-10 /pmc/articles/PMC3179154/ /pubmed/21954347 http://dx.doi.org/10.3390/ijms12085080 Text en © 2011 by the authors; licensee MDPI, Basel, Switzerland. http://creativecommons.org/licenses/by/3.0 This article is an open-access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/). |
spellingShingle | Article Tian, Yuanxin Xu, Jian Li, Zhonghuang Zhu, Zhengguang Zhang, Jiajie Wu, Shuguang Combined 3D-QSAR and Docking Modelling Study on Indolocarbazole Series Compounds as Tie-2 Inhibitors |
title | Combined 3D-QSAR and Docking Modelling Study on Indolocarbazole Series Compounds as Tie-2 Inhibitors |
title_full | Combined 3D-QSAR and Docking Modelling Study on Indolocarbazole Series Compounds as Tie-2 Inhibitors |
title_fullStr | Combined 3D-QSAR and Docking Modelling Study on Indolocarbazole Series Compounds as Tie-2 Inhibitors |
title_full_unstemmed | Combined 3D-QSAR and Docking Modelling Study on Indolocarbazole Series Compounds as Tie-2 Inhibitors |
title_short | Combined 3D-QSAR and Docking Modelling Study on Indolocarbazole Series Compounds as Tie-2 Inhibitors |
title_sort | combined 3d-qsar and docking modelling study on indolocarbazole series compounds as tie-2 inhibitors |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3179154/ https://www.ncbi.nlm.nih.gov/pubmed/21954347 http://dx.doi.org/10.3390/ijms12085080 |
work_keys_str_mv | AT tianyuanxin combined3dqsaranddockingmodellingstudyonindolocarbazoleseriescompoundsastie2inhibitors AT xujian combined3dqsaranddockingmodellingstudyonindolocarbazoleseriescompoundsastie2inhibitors AT lizhonghuang combined3dqsaranddockingmodellingstudyonindolocarbazoleseriescompoundsastie2inhibitors AT zhuzhengguang combined3dqsaranddockingmodellingstudyonindolocarbazoleseriescompoundsastie2inhibitors AT zhangjiajie combined3dqsaranddockingmodellingstudyonindolocarbazoleseriescompoundsastie2inhibitors AT wushuguang combined3dqsaranddockingmodellingstudyonindolocarbazoleseriescompoundsastie2inhibitors |